Drug · DIN 02567679
BOMYNTRA
SINGLE-USE VIAL
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since April 18, 2026.
- Drug Identification Number (DIN)
- 02567679
- Company (DIN owner)
- Fresenius Kabi Canada LtdToronto, Ontario, Canada
- Schedule
- Schedule D; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Denosumab M05BX04
- Class
- Human
- Record last updated
- August 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DENOSUMAB | 120 MG | 1.7 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 18, 2026: NOC 37444New Drug Submission (NDS)
Other DINs named BOMYNTRA
- DIN 02567687 · Approved